The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View
- PMID: 29128051
- PMCID: PMC6130315
- DOI: 10.1016/j.cld.2017.08.003
The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide, and its clinical and economic burden will continue to grow with parallel increases in rates of obesity, diabetes, and the metabolic syndrome. Evolving understanding of the natural history of NAFLD suggests that these patients are at risk for disease progression to steatohepatitis, fibrosis, and cirrhosis. Recent studies also suggest that these patients are at elevated risk for cardiovascular-, malignancy-, and liver-related morbidity and mortality, although their risk for progression, decompensation, and hepatocellular carcinoma may be less than that of patients with alternative causes of chronic liver disease.
Keywords: Cirrhosis; Fibrosis; Insulin resistance; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obesity; Steatosis.
Published by Elsevier Inc.
Conflict of interest statement
DISCLOSURE STATEMENT
The authors have nothing to disclose.
Similar articles
-
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014. Clin Liver Dis. 2018. PMID: 29128057 Review.
-
Natural History of Nonalcoholic Fatty Liver Disease.Dig Dis Sci. 2016 May;61(5):1226-33. doi: 10.1007/s10620-016-4095-4. Epub 2016 Mar 22. Dig Dis Sci. 2016. PMID: 27003142 Free PMC article. Review.
-
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484. Transplantation. 2019. PMID: 30335697 Review.
-
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24. Clin Liver Dis. 2016. PMID: 27063271 Review.
-
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5. Gastroenterology. 2018. PMID: 29733831
Cited by
-
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.World J Hepatol. 2022 Aug 27;14(8):1633-1642. doi: 10.4254/wjh.v14.i8.1633. World J Hepatol. 2022. PMID: 36157869 Free PMC article.
-
Regulation of Benzo[a]pyrene-Induced Hepatic Lipid Accumulation through CYP1B1-Induced mTOR-Mediated Lipophagy.Int J Mol Sci. 2024 Jan 22;25(2):1324. doi: 10.3390/ijms25021324. Int J Mol Sci. 2024. PMID: 38279324 Free PMC article.
-
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy.Front Med (Lausanne). 2021 Oct 21;8:737759. doi: 10.3389/fmed.2021.737759. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34746177 Free PMC article.
-
Adipose Tissue Composition in Obesity and After Bariatric Surgery.Obes Surg. 2019 Sep;29(9):3030-3038. doi: 10.1007/s11695-019-04030-z. Obes Surg. 2019. PMID: 31190263 Review.
-
Endoplasmic Reticulum and Mitochondria Contacts Correlate with the Presence and Severity of NASH in Humans.Int J Mol Sci. 2022 Jul 28;23(15):8348. doi: 10.3390/ijms23158348. Int J Mol Sci. 2022. PMID: 35955482 Free PMC article.
References
-
- Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980. July;55(7):434–8. - PubMed
-
- Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999. September;94(9):2467–74. - PubMed
-
- Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997. January 15;126(2):137–45. - PubMed
-
- Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol Baltim Md. 2005. June;41(6):1313–21. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical